2 | N-MYC regulates cell survival via eIF4G1 in inv(16) acute myeloid leukemia. (Peramangalam PS, Surapally S, Veltri AJ, Zheng S, Burns R, Zhu N, Rao S, Muller-Tidow C, Bushweller JH, Pulikkan JA) Sci Adv 2024 Mar;10(9):eadh8493 |
1 | MRI Features for Identifying MYCN-amplified RB1 Wild-type Retinoblastoma. (Jansen RW, de Bloeme CM, Cardoen L, Göricke S, van Elst S, Jessen JL, Ramasubramanian A, Skalet AH, Miller AK, Maeder P, Uner OE, Hubbard GB, Grossniklaus H, Boldt HC, Nichols KE, Brennan RC, Sen S, Sirin S, Brisse HJ, Galluzzi P, Dommering CJ, Castelijns JA, van der Valk P, Boellaard R, Dorsman J, Moll AC, de Jong MC, de Graaf P) Radiology 2023 Jun;307(5):e222264 2 Citations |
1 | FX11 inhibits aerobic glycolysis and growth of neuroblastoma cells. (Rellinger EJ, Craig BT, Alvarez AL, Dusek HL, Kim KW, Qiao J, Chung DH) Surgery 2017 Mar;161(3):747-752 28 Citations |
1 | Bromodomain and extraterminal inhibition blocks tumor progression and promotes differentiation in neuroblastoma. (Lee S, Rellinger EJ, Kim KW, Craig BT, Romain CV, Qiao J, Chung DH) Surgery 2015 Sep;158(3):819-26 24 Citations |
1 | Silencing of CDC42 inhibits neuroblastoma cell proliferation and transformation. (Lee S, Craig BT, Romain CV, Qiao J, Chung DH) Cancer Lett 2014 Dec 28;355(2):210-6 21 Citations |
1 | Peripheral neuroblastic tumors with genotype-phenotype discordance: a report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee. (Suganuma R, Wang LL, Sano H, Naranjo A, London WB, Seeger RC, Hogarty MD, Gastier-Foster JM, Look AT, Park JR, Maris JM, Cohn SL, Amann G, Beiske K, Cullinane CJ, d'Amore ES, Gambini C, Jarzembowski JA, Joshi VV, Navarro S, Peuchmaur M, Shimada H) Pediatr Blood Cancer 2013 Mar;60(3):363-70 27 Citations |